US2019350950A1PendingUtilityA1
Bovine milk oligosaccharides
Est. expiryJul 12, 2030(~4 yrs left)· nominal 20-yr term from priority
A23L 33/40C12P 19/14A23L 33/28A23V 2002/00A61K 31/715A61K 35/745A61K 36/062C08B 37/0003C12P 19/18A61K 31/702A61K 35/741C08L 5/00A61K 31/726C08B 37/006C08B 37/0063A23L 33/135C08L 2205/02
80
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Oligosaccharides from bovine milk, whey and dairy products, and methods of producing bovine milk oligosaccharides are provided.
Claims
exact text as granted — not AI-modified1 . A composition comprising galacto-oligosaccharides (GOS) and/or fructooligosaccharides (FOS) and/or lactulose and/or lactitol and/or xylooligosaccharides and an oligosaccharide from bovine milk or milk product and an inoculum of Bifidobacterium longum subsp. infantis or B. breve , wherein the oligosaccharide is selected from the group consisting of:
an oligosaccharide consisting of 3 Hexose (Hex) moieties, 4 n-acetyl hexosamine (HexNAc) moieties and 1 fucose (Fuc) moiety; an oligosaccharide consisting of 4 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 5 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 4 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 6 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties and 6 HexNAc moieties, an oligosaccharide consisting of 4 Hex moieties and 3 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 6 Hex moieties and 2 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 5 HexNAc moieties; an oligosaccharide consisting of 5 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 5 HexNAc moieties; and a mixture thereof.
2 . The composition of claim 1 comprising at least two oligosaccharides, wherein the at least two oligosaccharide are selected from the group consisting of:
an oligosaccharide consisting of 3 Hexose (Hex) moieties, 4 n-acetyl hexosamine (HexNAc) moieties and 1 fucose (Fuc) moiety;
an oligosaccharide consisting of 4 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety;
an oligosaccharide consisting of 3 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety;
an oligosaccharide consisting of 5 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety;
an oligosaccharide consisting of 4 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety;
an oligosaccharide consisting of 3 Hex moieties, 6 HexNAc moieties, and 1 Fuc moiety;
an oligosaccharide consisting of 3 Hex moieties and 6 HexNAc moieties,
an oligosaccharide consisting of 4 Hex moieties and 3 HexNAc moieties;
an oligosaccharide consisting of 3 Hex moieties and 4 HexNAc moieties;
an oligosaccharide consisting of 6 Hex moieties and 2 HexNAc moieties;
an oligosaccharide consisting of 4 Hex moieties and 4 HexNAc moieties;
an oligosaccharide consisting of 3 Hex moieties and 5 HexNAc moieties;
an oligosaccharide consisting of 5 Hex moieties and 4 HexNAc moieties;
an oligosaccharide consisting of 4 Hex moieties and 5 HexNAc moieties.
3 . The composition of claim 1 , further comprising a bovine milk protein, a soy protein, betalactoglobulin, whey, soybean oil or starch.
4 . The composition of claim 2 , further comprising a bovine milk protein, a soy protein, betalactoglobulin, whey, soybean oil or starch.
5 . The composition of claim 1 , further comprising a non-milk lipid.
6 . The composition of claim 2 , further comprising a non-milk lipid.
7 . The composition of claim 1 , wherein the composition is a solid.
8 . The composition of claim 5 , wherein the composition is a liquid and the content of the oligosaccharide in the composition is from 0.0001-100 g/L.
9 . A method of obtaining one or more of the oligosaccharides recited in claim 1 , comprising purifying the oligosaccharide from bovine milk and further comprising mixing the oligosaccharide with GOS and/or FOS and/or lactulose and/or lactitol and/or xylooligosaccharides.
10 . A method of treating a condition in an individual comprising administering an amount of a composition to the individual, wherein the composition comprises an oligosaccharide composition from bovine milk or milk product and an inoculum of Bifidobacterium longum subsp. infantis: an oligosaccharide in the oligosaccharide composition is selected from the group consisting of: an oligosaccharide consisting of 3 Hexose (Hex) moieties, 4 n-acetyl hexosamine (HexNAc) moieties and 1 fucose (Fuc) moiety; an oligosaccharide consisting of 4 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 5 Hex moieties, 4 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 4 Hex moieties, 5 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties, 6 HexNAc moieties, and 1 Fuc moiety; an oligosaccharide consisting of 3 Hex moieties and 6 HexNAc moieties, an oligosaccharide consisting of 4 Hex moieties and 3 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 6 Hex moieties and 2 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 3 Hex moieties and 5 HexNAc moieties; an oligosaccharide consisting of 5 Hex moieties and 4 HexNAc moieties; an oligosaccharide consisting of 4 Hex moieties and 5 HexNAc moieties; and a mixture thereof, wherein the oligosaccharide composition and the inoculum of Bifidobacterium longum subsp. infantis are administered in conjunction or the inoculum of Bifidobacterium longum subsp. infantis is included in the oligosaccharide composition.
11 . The method of claim 10 , wherein the method prevents necrotising enterocolitis in the individual.
12 . The method of claim 10 , wherein the individual is an infant of less than three months of age.
13 . The method of claim 11 , wherein the individual is a preterm infant.Join the waitlist — get patent alerts
Track US2019350950A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.